N phase. The microstructure of Ta-N coatings consists of nanocrystallites of about 15-20 nm in diameter, having a strong TaN(200)-oriented texture. Moreover, the coatings exhibit a uniform nanopillar structure on the surface, critical for the observed bioactivity. Scratching tests were performed to evaluate the adhesion strength between the Ta-N coatings and Ti-6Al-4V alloy substrates. The Ta-N coatings were found to exhibit a high scratch resistance and are thus suitable for load-bearing applications. The apatite-inducing ability of the coatings was evaluated in vitro using a simulated body fluid (SBF) that has almost equal compositions of inorganic ions to human blood plasma. After soaking in the solution for up to 14 days, only a few apatite particulates were observed on the surface of untreated Ti-6Al-4V alloy. By contrast, the surface of the Ta-N coatings was completely covered by a compact, AB-type apatite layer free of micro-cracks. High resolution transmission electron microscopy (HRTEM) observations reveal that after soaking for 14 days, the apatite layer, formed through a biomimetic process, comprises closely packed, needle-shaped apatite crystals of 34.5 ± 12.4 nm in length and 6.0 ± 0.2 nm in width. Moreover, nanotwins were identified in apatite, reminiscent of those found in bone minerals. The negatively-charged surface, combined with a unique surface structure of the Ta-N nanoceramic coatings, is believed to be responsible for the formation of a homogenous, compact bone-like apatite layer. The Ta-N nanoceramic coatings are expected to find applications as an integral part of biomaterials used in bone repair and replacement.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: